Breakthrough measures Parkinson’s progression in the brain

University of Florida researchers have identified a biomarker that shows the progression of Parkinson’s disease in the brain, opening the door to better diagnosis and treatment of the degenerative disease.

By comparing of Parkinson’s patients to those of a over a year, an interdisciplinary team found that an area of the brain called the substania nigra changes as the advances. The findings provide the first MRI-based method to measure the disease’s progression, which can inform treatment decisions and aid in identifying new therapies, said UF applied physiology and kinesiology professor David Vaillancourt, Ph.D., one of the study’s authors.

 

To read more click here!